目的 评价覆膜食管支架治疗食管癌放疗后并发食管狭窄或食管瘘的临床效果。方法 回顾性分析58例食管癌放疗后并发食管狭窄及食管瘘的患者,所有患者均在X线监视下放置Z形全覆膜食管支架,分析支架置入的疗效及安全性。结果 58例食管支架均放置成功,术后患者进食恢复通畅、瘘口封闭,各种临床症状得到有效迅速缓解,放置成功率及治疗有效率均为100.0%。术后出现胸痛52例(89.7%),恶心呕吐31例(53.4%),轻度消化道出血21例(36.2%),前两项经对症处理后可有效控制,后者自行好转。结论 采用覆膜食管支架治疗食管癌放疗后并发的食管狭窄及食管瘘简便、安全、疗效确切,值得推广。
Abstract
Objective To evaluate the clinical effect of covered esophageal stents in the treatment of esophageal stricture or esophageal fistula after radiotherapy for esophageal carcinoma.Methods A retrospective analysis of 58 patients with esophageal stenosis and esophageal fistula after radiotherapy for esophageal cancer was performed.All the patients were placed with Z covered esophageal stents under X-ray surveillance.The efficacy and side effects of stent implantation were analyzed.Results 58 cases of esophageal stents were placed successfully. The esophageal became unobstructed, fistula became sealed and a variety of clinical symptoms were effectively and quickly alleviated. The success rate of placement and treatment efficiency were 100%.Postoperative chest pain, nausea and vomiting, mild gastrointestinal bleeding occurred in 52 cases (89.7%), 31 cases (53.4%) and 21 cases (36.2%)respectively.The first two conditions were effectively controlled after symptomatic treatment, and the last one was improved on its own.Conclusions Covered esophageal stents in the treatment of esophageal stricture and esophageal fistula after radiotherapy for esophageal cancer are simple, safe, effective and worthy of popularization.
关键词
覆膜食管支架 /
食管癌 /
放疗 /
狭窄 /
瘘
Key words
covered esophageal stent /
esophageal cancer /
radiotherapy /
stenosis /
fistula
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Torre L A, Bray F, Siegel R L, et al.Global cancer statistics, 2012[J].Cancer,2015,65: 87-108.
[2] Jie H E, Shao K.The epidemiology,current status of management, challenge and future strategy for esophageal cancer in China[J].China Oncol, 2011, 21(7): 501-504.
[3] 殷蔚伯.肿瘤放射治疗学[M].4版.北京:中国协和医科大学出版社, 2008:553.
[4] Lambert R, Hainaut P.Epidemiology of oesophagogastric cancer [J].Best Pract Res Clin Gastroenterol, 2007, 21(6):921-945.
[5] Pennathur A, Gibson M K, Jobe B A, et al.Oesophageal carcinoma [J].Lancet, 2013,381:400-412.
[6] 黄智昊, 钟陆行.食管癌放疗技术及放疗方式研究进展[J].中国肿瘤临床, 2016, 43(12): 527-530.
[7] He J, Zeng Z C, Shi S M, et al.Clinical features, outcomes and treatment-related pneumonitis in elderly patients with esophageal carcinoma.[J].World J Gastroenterol, 2014, 20(36): 13185.
[8] 何 斌, 殷红梅, 崔 珍, 等.食管癌放疗后局部复发45例再程调强放疗分析[J].蚌埠医学院学报, 2015, 40(1): 23-25.
[9] Tsushima T, Mizusawa J, Sudo K, et al.Risk factors for esophageal fistula associated with chemoradiotherapy for locally advanced unresectable esophageal cancer: a supplementary analysis of JCOG0303[J].Medicine, 2016, 95(20): e3699.
[10] 李会勤, 仇学明.向移动式食管支架治疗食管癌放疗后狭窄[J].实用医学杂志, 2015, 31(2): 329-330.
[11] 师颖瑞, 王 晖, 杨敬儒,等.食管癌后程加速超分割调强适形放疗及联用尼妥珠单抗的研究[J].肿瘤研究与临床, 2014, 26(8): 514-517.
[12] 郭 琦.内镜下支架置入治疗高位食管-气管瘘的临床护理[J].上海护理, 2017, 17(3): 71-73.
PDF(603 KB)
